Radionetics Oncology represented by Paul Grayson and Brett Ewald participate in Fireside Chat hosted by Truist Securities
Radionetics Oncology’s Post
More Relevant Posts
-
Satej Bhogill and Catherine Chintala, PMP share what they enjoyed most at this year's #ASCO24 conference. Learn more about MERIT's oncology experience and solutions at https://lnkd.in/gD7rC9zQ #MERITCRO #YourClinicalEndpointExpert #imagingsolutions #clinicaltrials #clincialresearch #oncologytrials
ASCO 2024 Recap
To view or add a comment, sign in
-
Review what was discussed at the 2023 Precision Oncology Forum in regards to best practices & challenges involved in building an effective precision oncology program, by Jazieh et al. https://lnkd.in/gMk-HKtf #precisiononcology #JIPO
To view or add a comment, sign in
-
Are you aware of the recent implementation of the EU Clinical Trials Regulation No 536/2014 and how that will affect your oncology program? Find out in my team members’ blog: https://bit.ly/4d8eHdy
To view or add a comment, sign in
-
Anticipating potential barriers and roadblocks before they happen is key to the success of your oncology trial. To help you on your journey, we encourage you to consider these important questions: #oncologyresearch #clinicaltrials #oncologytrials
To view or add a comment, sign in
-
Medical Director | Medical Affairs | Physician Consultant | Cell & Gene Therapy Advisor | Drug Safety Physician — Hematology, Oncology & Rare Diseases
Are you aware of the recent implementation of the EU Clinical Trials Regulation No 536/2014 and how that will affect your oncology program? Find out in my team members’ blog: Navigating the Complex Regulatory CRO Landscape for Oncology Trials in the EU https://bit.ly/3WEcxga
To view or add a comment, sign in
-
Are you aware of the recent implementation of the EU Clinical Trials Regulation No 536/2014 and how that will affect your oncology program? Find out in my team members’ blog: https://bit.ly/3Yws1UO
To view or add a comment, sign in
-
Hello Boston. Translational Drug Development (TD2) is at Clinical Trials in Oncology East Coast. Visit our booth and learn how TD2 can help advance your cancer therapeutic program (from bench to bedside). While I won't be there (why did I hear a huge sigh of relief 😉), my colleague Parris Johnson is the man you want to speak with anyway. Don't worry, I'll be back for Tumor Models Boston in a couple weeks. #clinicaltrials #cancertherapeutic #oncology #tumormodelsboston #tumormodels #clinicaldevelopment #preclinical
Today's the day, TD2 is live in Boston at Clinical Trials in Oncology East Coast! Stop by to learn about our latest advancements in oncology research or follow the link to schedule a meeting: https://hubs.li/Q02FhSPg0
To view or add a comment, sign in
-
Is your site considering phase 1 oncology trials? SCRS has a guide that outlines several major considerations a site should explore when considering these types of trials. Access it here ⇢ https://lnkd.in/gBqrX2TX
To view or add a comment, sign in
-
From trial harmonization to economic impact, check out our white paper for a comprehensive and actionable guide for integrating PROs into your oncology program. https://bit.ly/490C2uZ
To view or add a comment, sign in
2,529 followers